MRPI Stock Overview
Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Mera Pharmaceuticals, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0003 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -99.00% |
3 Year Change | -99.99% |
5 Year Change | -99.75% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
MRPI | US Biotechs | US Market | |
---|---|---|---|
7D | 0% | -1.5% | -0.7% |
1Y | -99.0% | 0.1% | 22.3% |
Return vs Industry: MRPI underperformed the US Biotechs industry which returned 0.1% over the past year.
Return vs Market: MRPI underperformed the US Market which returned 22.3% over the past year.
Price Volatility
MRPI volatility | |
---|---|
MRPI Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 11.5% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.7% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MRPI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MRPI's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1983 | n/a | Benny Doro | n/a |
Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. The company is also involved in the development of sea salt; and operation of family entertainment center focused on promoting health and wellness through the Villari’s system of martial arts. In addition, it provides food production and delivery services.
Mera Pharmaceuticals, Inc. Fundamentals Summary
MRPI fundamental statistics | |
---|---|
Market cap | US$536.00 |
Earnings (TTM) | -US$10.28k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs MRPI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MRPI income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$10.28k |
Earnings | -US$10.28k |
Last Reported Earnings
Jul 31, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did MRPI perform over the long term?
See historical performance and comparison